Arkema has been pursuing a particularly ambitious bolt-on acquisitions program since 2007. These acquisitions have enabled the Group to reposition itself firmly in high performance materials, rebalance its global presence, and rank among world leaders in its main product lines.
With the investment in the JV Sunke (in partnership with Jurong Chemical, leader of acrylic acid in China) in 2014, the acquisitions of Bostik in 2015, Den Braven in 2016 and CMP in 2017, the Group has achieved an ambitious acquisition program of companies with high potential.
In 10 years, Arkema has acquired revenues of nearly 4 billion euros.
Over the coming years, Arkema will pursue its growth strategy based on bolt-on acquisitions by strongly focusing on specialties, which should represent more than 80% of its sales by 2023.
Arkema aims in particular to participate in the consolidation of the attractive, still-fragmented adhesives market, and will invest significantly in advanced materials (Technical Polymers and Performance Additives).